Ovarian Stimulation for IVF Procedures Dr Milton Leong 梁家康醫生 微剂量Flare法(1) 口服避孕药 皮下注射20mcg 亮丙瑞林 (一天两次)X2天 应用uFSH 以刺激卵巢 结果: 卵母细胞 FSH使用量少 Source: Scott et al, 1994 微剂量Flare法(2) 口服避孕药 皮下注射40mcg 亮丙瑞林 (一天两次) 肌注4 IU/d 生长激素 使用uFSH 2 天后监测 结果: 取消率 E2 浓度, 卵母细胞数目 Source: Schoolcraft et al, 1997 微剂量Flare法(3) 口服避孕药 皮下注射40mcg 亮丙瑞林 (一天两次) 2天后开始应用uFSH 结果: 取消率 E2, 卵母细胞数目 Source: Surrey et al, 1998 延长停药时间 (1) 目的: 避免过度刺激 临床: 直至 E2 3000 pg/mL停药 延长停药时间(2) Sher, 1995 当30% 卵泡 > 15mm开始 Nilsson, 1999 当3 个卵泡 > 17mm开始 GnRHa 剂量组 曲普瑞林 (mcg) 病例数 刺激天数 FSH使用量 S7-LH HCG-LH 排卵 5 15 50 100 11 9 24 3.3 2.5 3 10 7.5 22.5 1.5 2.3 0 11 10 27 1.3 1.8 0 12 10.5 28.5 0.8 0.9 0 Source: Janssens et al, 1998 Mean SE E2 and LH conc. Before and during the coasting period in superovluation cycles Characteristics of representative IVF-ET cycles in which coasting was used General Principles of combined pituitary suppression / ovarian stimulation therapy (From Insler and Lunenfeld) Clinical pregnancy per cycle start (%) Crude pregnancy rates using different GnRH agonist protocols in IVF (From Daya) 30 23.2 25 20 18.9 20.5 15 10 5 0 Short Ultrashort GnRH-a protocols Long The structure of GnRH agonistic analogues Outcome results according to type of protocol and gonadotrophin used (n=13426) Oocyte damage, pronuclear status and embryo cleavage after ICSI Trade names, plasma half-lives, relate potency, route of administration and recommended dose for the clinically available gonadotrophins Proposed protocols for poor responders Characteristics of IVF-ET cycles in which follicular maturity was attained before (gp 2A) or after (gp 2B) the coasting period Gonadotropin and ovarian steroid hormone levels with microdose flare regimen: gonadotropin treatment day 1 vs day 6 Comparison of conventional IVF and ICSI procedure on sibling oocytes of 50 patients with tubal infertility Outcome of embryo transfers after ICSI Schematic representation of different protocols using GnRH agonists in combination with gonadotrophins for ovarian stimulation in IVF Regimen@ Lupron Decapeptyl® 0.1 Alternate-day Decapeptyl® 0.1 7-day Total Cycle initiated 20 15 20 37.6 (32-44) 35.4 (32-42) 38.8 (36-44) 4.4 2.4 2.7 2.2 1.6 1.5 (P<0.05) 2.7 1.9 2.4 48.5 2473 35.0 1429 45.9 1760 Mean Age (range) Serum LH (IU/L) Day 3 Day 7 Day of hCG Serum E2 (pmol/L) Day 3 Day of hCG Regimen@ Lupron Decapeptyl® 0.1 Alternate-day Decapeptyl® 0.1 7-day Total Cycle initiated 20 15 20 37.6 (32-44) 35.4 (32-42) 38.8 (36-44) 10 74 5 25.0 6.5 77 2 13.4 9.6 86 6 30.0 Mean Age (range) Means # of eggs % fertilized # clinical pregnancy pregnancy rate %